Access the clinical profile, key features, and more in the links below. IMPORTANT SAFETY INFORMATION AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. See Prescribing Info (PI) below and full ISI at AJOVYhcp.com.
Download the Brochure for AJOVY
Download the full Prescribing Information